HASSAN EMIL E 4

What Happened
Emil E. Hassan, a director of National Healthcare Corp (NHC), exercised stock options on 2026-04-30 to acquire 7,500 common shares at an exercise price of $71.64 per share, for a total cash outlay of $537,300. The filing also records the corresponding derivative (the option) being disposed/converted (7,500 units at $0.00), reflecting the option-to-share conversion rather than an open-market sale.

Key Details

• Transaction date: 2026-04-30. Exercise price: $71.64; shares acquired: 7,500; total ≈ $537,300.
• Derivative conversion: 7,500 option units shown as disposed at $0.00 (conversion of the option into shares).
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: Options were granted under the 2020 Omnibus Equity Incentive Plan on May 6, 2021; grant and exercise are exempt from Section 16(b) under Rule 16b-3(d).
• Filing timeliness: Report filed 2026-05-01 for a 2026-04-30 transaction (timely within Form 4 reporting rules).

Context
This was an options exercise (insider acquiring shares), not an immediate sale on the open market. The record shows the option was converted into shares; there is no indication the shares were sold immediately (no sale reported). Exemptions cited mean the transaction is not subject to short-swing profit recovery under Section 16(b).